Similar Search Results

Price-cap regulation, uncertainty and the price evolution of new pharmaceuticals

Shajarizadeh, Ali; Hollis, Aidan - In: Health economics 24 (2015) 8, pp. 966-977

Persistent link: https://www.econbiz.de/10011318463

Regulating ambiguous risks : the less than rational regulation of pharmaceuticals

Viscusi, W. Kip; Zeckhauser, Richard - 2014

Persistent link: https://www.econbiz.de/10010251098

Regulating Ambiguous Risks : The Less than Rational Regulation of Pharmaceuticals

Viscusi, W. Kip; Zeckhauser, Richard J. - 2015

The U.S. Food and Drug Administration (FDA) balances risks and benefits before approving pharmaceuticals, as rationality would require. But powerful behavioral biases that lead to the mishandling of uncertainty also influence its approval process. The FDA places inordinate emphasis on errors of...

Persistent link: https://www.econbiz.de/10014148944

Combining Uncertainty with Uncertainty to Get Certainty? Efficiency Analysis for Regulation Purposes

Andor, Mark; Sommer, Stephan; Parmeter, Christopher - 2018

applied in incentive regulation practice, where the assessment of efficiency plays a major role in regulation design and … and SFA efficiency scores, have certain practical merits and might offer an useful alternative to strict reliance on a …, but can also improve the precision of efficiency estimation. Based on our results, we give recommendations for the …

Persistent link: https://www.econbiz.de/10014033300